نتایج جستجو برای: recurrent gastric cancer

تعداد نتایج: 1084955  

2012
Liangrong Shi Changping Wu Jun Wu Wenjie Zhou Mei Ji Hongyu Zhang Jiemin Zhao Yuanquan Huang Honglei Pei Zhong Li Jingfang Ju Jingting Jiang

BACKGROUND Locoregional recurrence is the typical pattern of recurrence in gastric cancer, and cannot be removed by surgery in most of the patients. We aimed to evaluate the feasibility and efficacy of computed tomography (CT)-guided brachytherapy for patients with locoregional recurrent gastric cancer. MATERIALS AND METHODS We reviewed the case histories of 28 patients with locoregional recu...

2012
Niantao Deng Liang Kee Goh Hannah Wang Kakoli Das Jiong Tao Iain Beehuat Tan Shenli Zhang Minghui Lee Jeanie Wu Kiat Hon Lim Zhengdeng Lei Glenn Goh Qing-Yan Lim Angie Lay-Keng Tan Dianne Yu Sin Poh Sudep Riahi Sandra Bell Michael M Shi Ronald Linnartz Feng Zhu Khay Guan Yeoh Han Chong Toh Wei Peng Yong Hyun Cheol Cheong Sun Young Rha Alex Boussioutas Heike Grabsch Steve Rozen Patrick Tan

OBJECTIVE Gastric cancer is a major gastrointestinal malignancy for which targeted therapies are emerging as treatment options. This study sought to identify the most prevalent molecular targets in gastric cancer and to elucidate systematic patterns of exclusivity and co-occurrence among these targets, through comprehensive genomic analysis of a large panel of gastric cancers. DESIGN Using hi...

2015
Yu Ishimine Akira Goto Yoshito Watanabe Hidetaka Yajima Suguru Nakagaki Takashi Yabana Takeya Adachi Yoshihiro Kondo Kiyoshi Kasai

Trastuzumab has recently been introduced as a treatment for HER2-positive metastatic and/or unresectable gastric cancer (MUGC); however, compared with breast cancer, some issues concerning HER2 and trastuzumab therapy for gastric cancer remain unclear. A 74-year-old woman received trastuzumab-containing chemotherapy for HER2-positive MUGC. She had a marked response to 8 months of chemotherapy, ...

2017
Kazuhiro Nishikawa Tsunehiro Takahashi Hiromasa Takaishi Akira Miki Hirokazu Noshiro Takaki Yoshikawa Yasunori Nishida Satoru Iwasa Hiroto Miwa Toshiki Masuishi Narikazu Boku Yasuhide Yamada Yasuhiro Kodera Kazuhiro Yoshida Satoshi Morita Junichi Sakamoto Shigetoyo Saji Yuko Kitagawa

Paclitaxel is a standard second-line gastric cancer treatment in Japan. Trastuzumab could be active as second-line chemotherapy for taxane/trastuzumab-naïve patients with epidermal growth factor 2 (HER2)-positive advanced gastric cancer. Patients aged ≥20 years with HER2-positive, previously treated (except for trastuzumab and taxane), unresectable or recurrent gastric adenocarcinoma underwent ...

Journal: :acta medica iranica 0
f. safarpour d. safarpour

cancer of the stomach carries poor prognosis. surgery is the best treatment for gastric cancer. prediction of survival depends on the stage at the time of presentation. fluoroscopy, sonography, and computerized tomography are used for advanced gastric cancers staging, but they are not accurate enough to grade advanced gastric cancers. laparoscopic findings of lesions under direct vision, are ma...

Journal: :research in molecular medicine 0
omolbanin amjadi km 17 khazarabad road, khazar sq, sari, iran alireza rafiei km 17 khazarabad road, khazar sq, sari, iran abolghasem ajami km 17 khazarabad road, khazar sq, sari, iran vahid hosseini inflammatory diseases of upper gi tract research center, department of internal medicine, faculty of medicine, mazandaran university of medical sciences, sari, iran. hossein asgarian-omran molecular and cell biology research center, department of immunology, faculty of medicine, mazandaran university of medicalsciences, sari, iran.

inflammatory condition is the consequence of defensive mechanism of immune system against viral and bacterial infection, tissue injury, uv radiation, stress and etc. persistently acute inflammation leads to chronic phase which is characterized by production of pro-inflammatory mediators from t cells. these molecules (e.g. il-6, tnf-α, il-1β and il-17) are mostly pleiotropic cytokines involved i...

Journal: :iranian journal of radiation research 0
f. samiei department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran a. maddah safaei department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran e. esmati department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran a. alibakhshi department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran ms. mirai ashtiani department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran p. haddad department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran

background: gastric cancer is an important health problem across the world. chemotherapy in combination with local treatment is standard treatment for locally advanced gastroesophageal cancers. the purpose of this investigation was evaluation of response and tolerability to neoadjuvant eox regimen in locoregionally advanced gastric cancer. materials and methods: patients with locoregionally adv...

2009
Semi Park Sang Joon Shin Joong Bae Ahn Hei-Cheul Jeung Sun Young Rha Sang Kil Lee Hyun Cheol Chung

Malignant obstruction develops frequently in advanced gastric cancer. Although it is primarily the gastric outlet that is obstructed, there are occasional reports of colonic obstruction. Treating intestinal obstruction usually requires emergency surgery or stent insertion. There are several kinds of complications with stent insertion, such as bowel perforation, stent migration, bleeding, abdomi...

اقدام ضمیری, رضا, جامه شورانی, مریم, مقیمی, مینوش,

Gastric cancer is one of the most common cancers in the world that can metastasize to other sites. The most common sites of metastasis are liver, lung, bone, and adrenal glands. Skin metastasis in gastric cancer is rare, and it usually occurs after diagnosis of primary cancer (1). The patient reported here is a 65-years old male with gastric adenocarcinoma that in the course of chemotherapy cam...

Journal: :Gut 1966
D J Martin

EDITORIAL COMMENT Conventional radiotherapy or chemotherapy has little success in the treatment of adenocarcinoma of the stomach. It is suggested that if radiotherapy can be given at times of tumour mitotic activity then greater success might be achieved. In this case a pattern of tumour activity was induced by Methotrexate and radiotherapy given during peaks of activity as judged by the Geiger...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید